1World Health Organization.The ICD210 Classification of Mental and Behavioral disorders:Clinical descriptions and diagnostic guidelimes[M].World Health Organization,1992:15-16.
1[1]American Psychiatric Association .DSM-IV[M].Washington DC:APA, 1994.393- 444
2[2]Hollifield M,Katon W,Skipper B,et al .Panic disorder and quality of life :variables predictive of functional impairment [J].Am J Psychiatry, 1997,154:766- 772
3[3]Mavissakalian MR,Perel JM,Talbott-Green M, et al .Gauging the effec-tiveness of extended imipramine treatment for panic disorder with agorap-phobia[J].Boil Psychiatry,1998,43:848- 854
4[4]Stein MB,Fyer AJ,Davidson JRT,et al.Fluvoxamine treatment of social phobia(social anxiety disorder):a double-blind ,placebo-controlled stud -y [J].Am J Psychiatry,1999,156: 756- 760
5[5]Zatzick DF,Marmar CR,Weiss DS,et al.Posttraumatic stress disorder and functioning and quality of life outcomes in a nationally repre -sen tative sample of male Vietnam veterans [J].Am J Psychiatry,1997,154: 1 690- 1 695
6[6]Koran LM,Thienemann ML,Davenport R.Qua ity of life for patients with obsessive-compulsive disorder [J].Am J Psychiatry,1996,153:783- 788
7[7]Schonfeld WH,VerboncoeurCJ,Fifer Sk,et al.The functioning and Well-being of patients with unrecognizd anxiety disorders and major depressive disorder[J].J Affect Disord ,1997,43:105- 119
8[1]Taylor GJ. Alexithymia:concept, measurement and implications for treatment. Am J Psychiatry, 1984,141:725.
9[2]Verma S, Gallagher RM. Evaluating and treating co-morbid pain and depression. International Review of Psychiatry, 2000,12:103.
